217 related articles for article (PubMed ID: 36735743)
1. Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species.
Rollin-Pinheiro R; Xisto MIDDS; de Castro-Almeida Y; Rochetti VP; Borba-Santos LP; Fontes YDS; Ferreira-Pereira A; Rozental S; Barreto-Bergter E
PLoS One; 2023; 18(2):e0280964. PubMed ID: 36735743
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of olorofim against clinical isolates of Scedosporium species and Lomentospora prolificans using EUCAST and CLSI methodologies.
Rivero-Menendez O; Cuenca-Estrella M; Alastruey-Izquierdo A
J Antimicrob Chemother; 2020 Dec; 75(12):3582-3585. PubMed ID: 32856079
[TBL] [Abstract][Full Text] [Related]
3. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Wiederhold NP; Law D; Birch M
J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations and susceptibility of Scedosporium/Lomentospora infections at a tertiary medical centre in Taiwan from 2014 to 2021: A retrospective cohort study.
Lao CK; Ou JH; Fan YC; Wu TS; Sun PL
Mycoses; 2023 Oct; 66(10):923-935. PubMed ID: 37449538
[TBL] [Abstract][Full Text] [Related]
5. Identification of Promising Antifungal Drugs against
Rollin-Pinheiro R; Borba-Santos LP; da Silva Xisto MID; de Castro-Almeida Y; Rochetti VP; Rozental S; Barreto-Bergter E
J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682224
[TBL] [Abstract][Full Text] [Related]
6. Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the Scedosporium/Lomentospora genera.
Mello TP; Oliveira SSC; Branquinha MH; Santos ALS
Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35641191
[TBL] [Abstract][Full Text] [Related]
7.
Georgacopoulos O; Nunnally N; Law D; Birch M; Berkow EL; Lockhart SR
Microbiol Spectr; 2023 Feb; 11(1):e0278922. PubMed ID: 36629417
[No Abstract] [Full Text] [Related]
8. In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus.
Kirchhoff L; Dittmer S; Buer J; Rath PM; Steinmann J
Int J Antimicrob Agents; 2020 Sep; 56(3):106105. PubMed ID: 32721601
[TBL] [Abstract][Full Text] [Related]
9.
Furnica DT; Dittmer S; Scharmann U; Meis JF; Steinmann J; Rath PM; Kirchhoff L
Microbiol Spectr; 2023 Jun; 11(3):e0513022. PubMed ID: 37017567
[TBL] [Abstract][Full Text] [Related]
10. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Castanheira M; Duncanson FP; Diekema DJ; Guarro J; Jones RN; Pfaller MA
Antimicrob Agents Chemother; 2012 Jan; 56(1):352-7. PubMed ID: 22083469
[TBL] [Abstract][Full Text] [Related]
11. Miltefosine Against
Rollin-Pinheiro R; Almeida YC; Rochetti VP; Xisto MIDDS; Borba-Santos LP; Rozental S; Barreto-Bergter E
Front Cell Infect Microbiol; 2021; 11():698662. PubMed ID: 34368017
[No Abstract] [Full Text] [Related]
12.
Seyedmousavi S; Chang YC; Youn JH; Law D; Birch M; Rex JH; Kwon-Chung KJ
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0043421. PubMed ID: 34252298
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of auranofin and honokiol as antifungals against
Yaakoub H; Staerck C; Mina S; Godon C; Fleury M; Bouchara JP; Calenda A
Virulence; 2021 Dec; 12(1):1076-1090. PubMed ID: 33825667
[TBL] [Abstract][Full Text] [Related]
14. Cell dispersion during biofilm formation by
Mello TP; Barcellos IC; Branquinha MH; Santos ALS
Curr Res Microb Sci; 2023; 4():100191. PubMed ID: 37229517
[TBL] [Abstract][Full Text] [Related]
15. Impact of biofilm formation and azoles' susceptibility in Scedosporium/Lomentospora species using an in vitro model that mimics the cystic fibrosis patients' airway environment.
Mello TP; Lackner M; Branquinha MH; Santos ALS
J Cyst Fibros; 2021 Mar; 20(2):303-309. PubMed ID: 33334714
[TBL] [Abstract][Full Text] [Related]
16. Antibiofilm activity of antifungal drugs, including the novel drug olorofim, against Lomentospora prolificans.
Kirchhoff L; Dittmer S; Weisner AK; Buer J; Rath PM; Steinmann J
J Antimicrob Chemother; 2020 Aug; 75(8):2133-2140. PubMed ID: 32386411
[TBL] [Abstract][Full Text] [Related]
17. Conidial germination in Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans: influence of growth conditions and antifungal susceptibility profiles.
Mello TP; Aor AC; Oliveira SS; Branquinha MH; Santos AL
Mem Inst Oswaldo Cruz; 2016 Jun; 0(7):0. PubMed ID: 27355215
[TBL] [Abstract][Full Text] [Related]
18. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
Lackner M; de Hoog GS; Verweij PE; Najafzadeh MJ; Curfs-Breuker I; Klaassen CH; Meis JF
Antimicrob Agents Chemother; 2012 May; 56(5):2635-42. PubMed ID: 22290955
[TBL] [Abstract][Full Text] [Related]
19. Scedosporium aurantiacum: First isolation in Argentina from a previously healthy patient after traumatic inoculation.
Carnovale S; Epelbaum C; Abrantes R; Córdoba S; Cabrera C; Caracciolo B
Rev Argent Microbiol; 2022; 54(4):318-321. PubMed ID: 35643584
[TBL] [Abstract][Full Text] [Related]
20. Active Cu(II), Mn(II) and Ag(I) 1,10-phenanthroline/1,10-phenanthroline-5,6-dione/dicarboxylate chelates: effects on
Mello TP; Aor AC; Barcellos IC; Pereira MM; McCann M; Devereux M; Branquinha MH; Santos AL
Future Microbiol; 2023 Nov; 18():1049-1059. PubMed ID: 37284767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
